A Telemedicine Approach for Monitoring COPD : A Prospective Feasibility and Acceptability Cohort Study
© 2022 Shinoda et al..
Background: Telemedicine may help the detection of symptom worsening in patients with chronic obstructive pulmonary disease (COPD), potentially resulting in improved outcomes. This study aimed to determine the feasibility and acceptability of telemedicine among patients with COPD and physicians and facility staff in Japan.
Methods: This was a 52-week multicenter, prospective, single-arm, feasibility and acceptability cohort study of Japanese patients ≥40 years of age with COPD or asthma-COPD overlap. Participants underwent training to use YaDoc, a telemedicine smartphone App, which included seven daily symptom questions and weekly COPD Assessment Test (CAT) questions. The primary endpoint was participant compliance for required question completion. The secondary endpoint was participant and physician/facility staff acceptability of YaDoc based on questionnaires completed at Week 52. The impact of the Japanese COVID-19 pandemic state of emergency on results was also assessed.
Results: Of the 84 participants enrolled (mean age: 68.7 years, 88% male), 72 participants completed the study. Completion was high in the first six months but fell after that. Median (interquartile range [IQR]) compliance for daily questionnaire entry was 66.6% (31.0-91.8) and 81.0% (45.3-94.3) for weekly CAT entry. Positive participant responses to the exit questionnaire were highest regarding YaDoc ease of use (83.8%), positive impact on managing health (58.8%), and overall satisfaction (53.8%). Of the 26 physicians and facility staff enrolled, 24 completed the study. Of these, the majority (66.7%) responded positively regarding app facilitation of communication between physicians and participants to manage disease. Compliance was similar before and after the first COVID-19 state of emergency in Japan.
Conclusion: Daily telemedicine monitoring is potentially feasible and acceptable to both patients and physicians in the management of COPD. These results may inform potential use of telemedicine in clinical practice and design of future studies.
Clinical Trial Registration: JapicCTI-194916.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
International journal of chronic obstructive pulmonary disease - 17(2022) vom: 17., Seite 2931-2944 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shinoda, Masahiro [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Acceptability |
|---|
| Anmerkungen: |
Date Completed 25.11.2022 Date Revised 30.11.2022 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.2147/COPD.S375049 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM349330344 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM349330344 | ||
| 003 | DE-627 | ||
| 005 | 20231226042346.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2147/COPD.S375049 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1164.xml |
| 035 | |a (DE-627)NLM349330344 | ||
| 035 | |a (NLM)36419950 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Shinoda, Masahiro |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A Telemedicine Approach for Monitoring COPD |b A Prospective Feasibility and Acceptability Cohort Study |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.11.2022 | ||
| 500 | |a Date Revised 30.11.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 Shinoda et al. | ||
| 520 | |a Background: Telemedicine may help the detection of symptom worsening in patients with chronic obstructive pulmonary disease (COPD), potentially resulting in improved outcomes. This study aimed to determine the feasibility and acceptability of telemedicine among patients with COPD and physicians and facility staff in Japan | ||
| 520 | |a Methods: This was a 52-week multicenter, prospective, single-arm, feasibility and acceptability cohort study of Japanese patients ≥40 years of age with COPD or asthma-COPD overlap. Participants underwent training to use YaDoc, a telemedicine smartphone App, which included seven daily symptom questions and weekly COPD Assessment Test (CAT) questions. The primary endpoint was participant compliance for required question completion. The secondary endpoint was participant and physician/facility staff acceptability of YaDoc based on questionnaires completed at Week 52. The impact of the Japanese COVID-19 pandemic state of emergency on results was also assessed | ||
| 520 | |a Results: Of the 84 participants enrolled (mean age: 68.7 years, 88% male), 72 participants completed the study. Completion was high in the first six months but fell after that. Median (interquartile range [IQR]) compliance for daily questionnaire entry was 66.6% (31.0-91.8) and 81.0% (45.3-94.3) for weekly CAT entry. Positive participant responses to the exit questionnaire were highest regarding YaDoc ease of use (83.8%), positive impact on managing health (58.8%), and overall satisfaction (53.8%). Of the 26 physicians and facility staff enrolled, 24 completed the study. Of these, the majority (66.7%) responded positively regarding app facilitation of communication between physicians and participants to manage disease. Compliance was similar before and after the first COVID-19 state of emergency in Japan | ||
| 520 | |a Conclusion: Daily telemedicine monitoring is potentially feasible and acceptable to both patients and physicians in the management of COPD. These results may inform potential use of telemedicine in clinical practice and design of future studies | ||
| 520 | |a Clinical Trial Registration: JapicCTI-194916 | ||
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Japan | |
| 650 | 4 | |a acceptability | |
| 650 | 4 | |a feasibility | |
| 650 | 4 | |a patient-reported outcome measure | |
| 650 | 4 | |a smartphone | |
| 650 | 4 | |a telemonitoring | |
| 700 | 1 | |a Hataji, Osamu |e verfasserin |4 aut | |
| 700 | 1 | |a Miura, Motohiko |e verfasserin |4 aut | |
| 700 | 1 | |a Kinoshita, Masaharu |e verfasserin |4 aut | |
| 700 | 1 | |a Mizoo, Akira |e verfasserin |4 aut | |
| 700 | 1 | |a Tobino, Kazunori |e verfasserin |4 aut | |
| 700 | 1 | |a Soutome, Toru |e verfasserin |4 aut | |
| 700 | 1 | |a Nishi, Takanobu |e verfasserin |4 aut | |
| 700 | 1 | |a Ishii, Takeo |e verfasserin |4 aut | |
| 700 | 1 | |a Miller, Bruce E |e verfasserin |4 aut | |
| 700 | 1 | |a Tal-Singer, Ruth |e verfasserin |4 aut | |
| 700 | 1 | |a Tomlinson, Ryan |e verfasserin |4 aut | |
| 700 | 1 | |a Matsuki, Taizo |e verfasserin |4 aut | |
| 700 | 1 | |a Jones, Paul W |e verfasserin |4 aut | |
| 700 | 1 | |a Shibata, Yoko |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of chronic obstructive pulmonary disease |d 2006 |g 17(2022) vom: 17., Seite 2931-2944 |w (DE-627)NLM175408165 |x 1178-2005 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2022 |g day:17 |g pages:2931-2944 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2147/COPD.S375049 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2022 |b 17 |h 2931-2944 | ||